TickerFacts.

Dianthus Therapeutics, Inc. (DNTH): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Older than the company's other figures. The latest Free Cash Flow is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report Capital Expenditures, which Free Cash Flow is computed from, under the concepts TickerFacts maps.

-$29.38M
Year ended 2022-12-31
2016-12-31: -$6.67M2017-12-31: -$24.46M2018-12-31: -$49.56M2019-12-31: -$60.16M2020-12-31: -$64.42M2021-12-31: -$60.80M2022-12-31: -$29.38M-$29.38M
2016-12-31 Free Cash Flow (USD) 2022-12-31
Period endedFree Cash FlowChange YoYSource filing
2022-12-31-$29.38Mn/m2024-03-21, From 2022-01-01
2021-12-31-$60.80Mn/m2023-03-23, From 2021-01-01
2020-12-31-$64.42Mn/m2022-03-08, From 2020-01-01
2019-12-31-$60.16Mn/m2021-03-03, From 2019-01-01
2018-12-31-$49.56Mn/m2020-03-03, From 2018-01-01
2017-12-31-$24.46Mn/m2020-03-03, From 2017-01-01
2016-12-31-$6.67Mn/a2019-03-19, From 2016-01-01